|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Feng Q, Wei X and Yu Y: MicroRNA-490
regulates lung cancer metastasis by targeting poly r(C)-binding
protein 1. Tumour Biol. 37:15221–15228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ourari-Dhahri B, Ben Slima H, Ben Amar J,
El Gharbi L, Ali M and Baccar Azzabi S: Management of non-small
cell lung cancer. Tunis Med. 90:847–851. 2012.PubMed/NCBI
|
|
4
|
Zamay TN, Zamay GS, Kolovskaya OS, Zukov
RA, Petrova MM, Gargaun A, Berezovski MV and Kichkailo AS: Current
and prospective protein biomarkers of lung cancer. Cancers.
9:E1552017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lazzari C, Spreafico A, Bachi A, Roder H,
Floriani I, Garavaglia D, Cattaneo A, Grigorieva J, Viganò MG,
Sorlini C, et al: Changes in plasma mass-spectral profile in course
of treatment of non-small cell lung cancer patients with epidermal
growth factor receptor tyrosine kinase inhibitors. J Thorac Oncol.
7:40–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang Y, Qiao G, Xu E, Xuan Y, Liao M and
Yin G: Biomarkers for early diagnosis, prognosis, prediction, and
recurrence monitoring of non-small cell lung cancer. Onco Targets
Ther. 12:4527–4534. 2017. View Article : Google Scholar
|
|
7
|
Lou W, Liu J, Gao Y, Zhong G, Chen D, Shen
J, Bao C, Xu L, Pan J, Cheng J, et al: MicroRNAs in cancer
metastasis and angiogenesis. Oncotarget. 8:115787–115802. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Q, Huang SX, Zhang F, Li SJ, Liu C,
Xi YY, Wang L, Wang X, He QQ, Sun CC and Li DJ: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50:2017. View Article : Google Scholar
|
|
9
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan
M, Jeon YJ, Li B, Vicentini C, Peng Y, et al: MicroRNA-224 promotes
tumor progression in non-small cell lung cancer. Proc Natl Acad Sci
USA. 112:E4288–E4297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng W, Ye Z, Cui R, Perry J,
Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H,
et al: MicroRNA-31 predicts the presence of lymph node metastases
and survival in patients with lung adenocarcinoma. Clin Cancer Res.
19:5423–5433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adams BD, Guo S, Bai H, Guo Y, Megyola CM,
Cheng J, Heydari K, Xiao C, Reddy EP and Lu J: An in vivo
functional screen uncovers miR-150-mediated regulation of
hematopoietic injury response. Cell Rep. 2:1048–1060. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: MiR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem. Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang N, Wei X and Xu L: miR-150 promotes
the proliferation of lung cancer cells by targeting P53.
FEBS Lett. 587:2346–2351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X1, Wang C, Zhang J, Zen K, et al: miR-150 promotes the
proliferation and migration of lung cancer cells by targeting SRC
kinase signaling inhibitor 1. Eur J Cancer. 50:1013–1024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu W, Jiang K, Shen M, Qian Y and Peng Y:
SIRT2 suppresses non-small cell lung cancer growth by targeting
JMJD2A. Biol Chem. 396:929–936. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu W, Jiang K, Shen M, Chen Y and Huang
HY: Jumonji domain containing 2A predicts prognosis and regulates
cell growth in lung cancer depending on miR-150. Oncol Rep.
35:352–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Orellana EA and Kasinski AL: MicroRNAs in
cancer: A historical perspective on the path from discovery to
therapy. Cancers. 7:1388–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frixa T, Donzelli S and Blandino G:
Oncogenic MicroRNAs: Key players in malignant transformation.
Cancers. 7:2466–2485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inamura K and Ishikawa Y: MicroRNA in lung
cancer: Novel biomarkers and potential tools for treatment. J Clin
Med. 5:pii: E36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi RU, Miyazaki H and Ochiya T: The
roles of MicroRNAs in breast cancer. Cancers. 7:598–616. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He Y, Jiang X and Chen J: The role of
miR-150 in normal and malignant hematopoiesis. Oncogene.
33:3887–3893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang S, Chen Y, Wu W, Ouyang N, Chen J,
Li H, Liu X, Su F, Lin L and Yao Y: miR-150 promotes human breast
cancer growth and malignant behavior by targeting the pro-apoptotic
purinergic P2X7 receptor. PLoS One. 8:e807072013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yokobori T, Suzuki S, Tanaka N, Inose T,
Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H and Kuwano
H: MiR-150 is associated with poor prognosis in esophageal
squamous cell carcinoma via targeting the EMT inducer ZEB1.
Cancer Sci. 104:48–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun W, Zhang Z, Wang J, Shang R, Zhou L,
Wang X, Duan J, Ruan B, Gao Y, Dai B, et al: MicroRNA-150
suppresses cell proliferation and metastasis in hepatocellular
carcinoma by inhibiting the GAB1-ERK axis. Oncotarget.
7:11595–11608. 2016.PubMed/NCBI
|
